SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-049927
Filing Date
2017-08-07
Accepted
2017-08-07 16:50:02
Documents
10
Period of Report
2017-08-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-18560_48k.htm 8-K 33847
2 EX-4.1 a17-18560_4ex4d1.htm EX-4.1 840200
3 EX-99.1 a17-18560_4ex99d1.htm EX-99.1 12944
4 GRAPHIC g185604ki11i001.gif GRAPHIC 865
5 GRAPHIC g185604ki11i002.gif GRAPHIC 954
6 GRAPHIC g185604ki11i003.gif GRAPHIC 990
7 GRAPHIC g185604ki11i004.gif GRAPHIC 1005
8 GRAPHIC g185604ki11i005.gif GRAPHIC 852
9 GRAPHIC g185604ki11i006.gif GRAPHIC 1284
10 GRAPHIC g185604mmi001.jpg GRAPHIC 3816
  Complete submission text file 0001104659-17-049927.txt   903041
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 171012141
SIC: 2834 Pharmaceutical Preparations